Jacaranda is one of the genera of Bignoniaceae endemic to South America and is now widely distributed in the tropical and subtropical areas of the world. Some species are used in traditional medicine in various countries for the treatment of wounds, rheumatism, colds and skin diseases (1). More recently, a review of the ethnobotanical and pharmacological uses of Jacaranda species has pointed out its interesting phytochemical constituents and biological activities such as anti-dyspeptic, cytotoxic, anti-malarial and lipooxygenase inhibitory activity as well as antimicrobial activities (2). Jacaranda obtu-
sifolia H. B. K. ssp. rhombifolia (G. F. W. Meijer) Gentry is a medium-sized, deciduous tree with a variably shaped crown and is now commonly cultivated in Thailand (3) . Previously, we reported the isolation and structure elucidation of a 7-hydroxy-3'-methoxy-4'--O-b-D-glucoside isoflavone, daidzein, and genistin from J. obtusifolia. The isolated compounds possess significant anticancer activity (4) . Therefore, in continuation of this work we focused on the isolation of different fractions and subfractions of J. obtusifolia and evaluation of their anticancer activity.
EXPERIMENTAL

General experimental procedures
All NMR spectra were recorded on a Bruker Avance (500 MHz) spectrometer (USA). 1 H and 13 C spectra were recorded relative to MeOH-d 4 (d = 3.30 and 49.0 ppm, respectively). Low resolution electrospray ionization mass spectra (LR-ESIMS) were measured on a Finnigan MAT 900 XL double focusing magnetic sector mass spectrometer (Finnigan, Germany). Optical rotations were measured on a Perkin-Elmer 241 MC polarimeter (USA) with a 10-cm path length. Reverse phase TLC was carried out on precoated silica gel aluminium-backed plates (RP-18 F 254s , 0.25 mm thick, Merck, Germany). The plates were first viewed under UV light at 254 and 365 nm, then spotted using 3 % cerium sulfate in 2 mol L -1 H 2 SO 4 , followed by heating. Flash column chromatography was carried out using RP-C 18 silica gel (40-60 mm, Merck). Reverse phase high performance liquid chromatography (RP-HPLC) was performed on an Agilent 1100 system (USA) with UV detection at 254 nm using a Phenomenex Gemini (5 mm) C 18 (10 mm´250 mm) semipreparative column.
Plant material
Twigs of J. obtusifolia were collected in July 2008. The plant material was identified by J. F. Maxwell (Department of Biology, Faculty of Science, Chiang Mai University, Thailand), and a voucher specimen was deposited at the CMU Herbarium and Faculty of Pharmacy, of the same university.
Extraction and isolation
Dried twigs of J. obtusifolia (1 kg) were ground and extracted successively with 2.5 L of n-hexane, CHCl 3 and MeOH at room temperature, followed by filtration through a Whatman No. 1 filter paper. The hexane, CHCl 3 and MeOH extracts were concentrated under vacuum using a rotary evaporator (Büchi, Switzerland) to afford crude extracts as follows: crude hexane extract (dark green syrup 2.8 g), crude CHCl 3 extract (brownish sticky solid 7.6 g) and crude MeOH extract (dark brownish sticky solid 9.3 g), and were then stored in the refrigerator.
The methanolic extract (0.88 g) was purified by reverse-phase flash column chromatography on RP-C 18 silica gel (160 g) with gradient elution using MeOH/H 2 O; 25 : 75, 50 : 50, 75 : 25 and 100 : 0, V/V, each 300 mL (each collection was 100 mL) in the order of decreasing polarity. The eluents were collected, monitored by TLC and 1 H NMR, producing 7 groups of eluting fractions. The solvents were evaporated to dryness in vacuo to afford 7 major fractions: J1 (0.15 g), J2 (0.03 g), J3 (0.34 g), J4 (0.02 g), J5 (0.05 g), J6 (0.02 g) and J7 (0.02 g). Fraction J3 was further purified by RP-HPLC. Elution was conducted initially with 50 % MeOH/H 2 O up to 100 % MeOH (for 40 min, flow rate 1.5 mL min -1 , UV detection at 254 nm) to give 9 subfractions: J31 to J39 (compound 1, 2.2 mg, t R = 20.2 min). Subfraction J32 (5 mg) was purified by RP-HPLC using the same conditions to give 4 subfractions J321-J324. J323 (2.2 mg) was subjected to further RP-HPLC purification (60 % MeOH/H 2 O up to 100 % MeOH) to afford compounds 2 (1.2 mg, t R = 12.7 min) and 4 (0.75 mg, t R = 19.0 min). Fraction J5 (30 mg) was purified by RP-HPLC using gradient elution from MeOH/water (80 : 20) to 100 % MeOH to afford compounds 3 (1.5 mg, t R = 11.6 min) and 5 (0.8 mg, t R = 12.8 min) (Scheme 1).
Anticancer activity
Cytotoxic assays of crude extracts and the isolated compounds against three cancerous human-cell lines: KB cell line (epidermoid carcinoma of oral cavity, ATCC CCL-17), MCF-7 cell line (breast adenocarcinoma, ATCC HTB-22) and NCI-H 187 cell line (small cell lung carcinoma, ATCC CRL-5804) were performed employing the resazurin microplate assay (REMA) as described by Brien et al. (5) with suitable modification. Briefly, cells in a logarithmic growth phase were harvested and diluted to 7´10 4 cells mL -1 for KB and 9´10 4 cells mL -1 for MCF-7 and NCI-H 187, in fresh medium. Successively, 5 mL of the essential oil was diluted in 5 % DMSO, and 45 mL of cell suspension was added to 384-well plates, incubated at 37°C in a 5 % CO 2 incubator. After the incubation period (3 days for KB and MCF-7, and 5 days for NCI-H187), 12.5 mL of 62.5 mg mL -1 resazurin so- lution was added to each well, and the plates were then incubated at 37°C for 4 hours. The fluorescence signal was measured using a SpectraMax M5 multi-detection microplate reader (Molecular Devices, USA) at excitation and emission wavelengths of 530 nm and 590 nm. The inhibitory concentration (IC 50 ) represented the concentration that caused 50 % reduction in cancer cell line growth. The cytotoxicity assay against Vero cells (African green monkey kidney) was performed using a green fluorescent protein (GFP)--based assay (6).
RESULTS AND DISCUSSION
The methanolic extract of J. obtusifolia twigs was purified by reverse phase flash column chromatography on RP-C 18 silica gel, followed by reverse phase HPLC purification resulting in the isolation of five flavonoids. The isolated compounds were identified as: (-)-liquiritigenin (1), (-)-neoliquiritin (2), isoliquiritigenin (3), isoliquiritin (4) and formononetin (5). The isolated compounds were identified by spectroscopic analysis ( 1 H, 13 C NMR, 2D NMR and MS) (Fig. 1 , Tables I and II) . This data was also confirmed by comparison with previously reported spectral data. This extract was selected for its anticancer activity (small cell lung cancer with IC 50 value of 23.2 mg mL -1 ) (Table III) .
Chemistry
Compound 1 was isolated as an amorphous yellowish solid. The LR-ESIMS mass spectrum showed the molecular ion peak at m/z 279.1 [M + Na + ]. The 1 H NMR (Table I) 
16.9
Hz, H-3) were attributed to a CH-CH 2 system. On this basis and comparison of 1 H (Table I ) and 13 C NMR data (Table II) with published values (7) quiritigenin and so compound 1 had the same configuration as liquiritigenin previously published in the literature (8) . Flavanones with a 2S configuration and having a C-2 equatorial aryl group are known to be laevorotatory (9) . The C-2 aryl substituent was in the equatorial orientation, as evident from the large J 2,3ax (13.0 Hz). Thus, the absolute configuration at C-2 of compound 1 was confirmed as S. The 1 H NMR (Table I ) data for compound 2 suggested a structure similar to that of compound 1, differing only in the sugar moiety. An analysis of the sugar unit was completed using DQF-COSY, 1D-TOCSY, HSQC and HMBC data and led to its identification as b-glucose. (10) , despite the different concentrations used. Compound 2 was identified as (-)-neoliquiritin and indicated that C-2 had the S configuration. In nature, only D sugars occur in abundance. From the negative specific rotation value found, the sugar unit should be b-D-glucopyranoside (11). The LR-ESIMS displayed a molecular ion peak at m/z 441.0 [M+Na + ] in agreement with the structure of compound 2.
The 1 H NMR data (Table I) (Table I ) and 13 C NMR data (Table II) with previously published spectral data (7) suggested that compound 3 was 
